Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Youth Cannabis Use Disorder
NCT03055377Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2017
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Aug 2017; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03055377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055377.